Glide Control for Upper Extremity Amputation

Overseen By Rahul R Kaliki, Ph.D

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Infinite Biomedical Technologies

Disqualifiers: Unhealed wounds, Cognitive deficits, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Approved in 2 Jurisdictions This treatment is already approved in other countries

Compensation: Varies

Number of Visits: 1

7 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial evaluates a new prosthesis control strategy called Glide to determine if it helps individuals with arm amputations use their prosthetics more effectively. It compares Glide with the usual control method, Direct Control (DC), by having participants use each method for a set period. The trial seeks to determine if Glide improves function, satisfaction, and prosthesis usage frequency. Individuals with a single arm amputation below the elbow who qualify for a myoelectric (muscle-controlled) prosthetic hand may be suitable for this study. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance prosthetic technology for future users.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It would be best to discuss this with the study team.

What prior data suggests that the Glide Control Strategy is safe for use in upper extremity amputation?

Research has shown that myoelectric control systems, such as the Glide Control Strategy, are generally safe for use. Although specific safety data for Glide Control is lacking, extensive use has not resulted in reports of serious problems, suggesting the treatment is well-tolerated.

When a trial is labeled "not applicable" in phase, it often indicates limited human safety data. However, the use of similar technology in other areas provides some confidence about its safety. Prospective participants should feel free to ask questions if they have concerns about joining a trial. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about the Glide Control Strategy for upper extremity amputation because it offers a novel way to operate prosthetic limbs. Unlike traditional prosthetics that rely on direct control, this strategy introduces a "Glide" mode that could provide smoother, more intuitive control for users. This means that amputees may experience improved functionality and ease of use with their prosthetics, potentially enhancing their quality of life. The Glide Control Strategy aims to bridge the gap between user intent and prosthetic movement, offering a more natural interaction compared to existing options.

What evidence suggests that the Glide Control Strategy is effective for upper extremity amputation?

This trial will evaluate the Glide Control Strategy, which employs a special control system to make prosthetic limbs easier and more natural to use. Studies have shown that this method, tested in labs with individuals who have lost their lower arm, suggests users find it easier to perform tasks, feel more satisfied, and use the prosthetic more effectively compared to regular prosthetic controls. The Glide system aims to help users feel more connected to their prosthetic limb, simplifying and enhancing everyday activities. Participants in this trial will use the Glide Control Strategy during specific phases to assess its effectiveness. ^{2 4 6 7 8}

Are You a Good Fit for This Trial?

This trial is for individuals with upper extremity amputation. Participants will use two types of prosthetic arms: a standard Direct Control (DC) prosthesis and an experimental Glide prosthesis, over a period of 24 weeks to compare functionality, satisfaction, and usage.

Inclusion Criteria

Candidate for a multi-articulated myoelectric hand prosthesis as determined by the study prosthetist

I have lost one arm.

Minimal residual limb length for myoelectric control as determined by the clinical team

Exclusion Criteria

My health issues are under control.

My amputation site has not fully healed.

My limb's condition may prevent me from fully participating in the study.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline (A Phase)

Participants use the Direct Control (DC) prosthesis for baseline measurements and daily activities

10-14 weeks

Weekly data submission via web portal

Crossover

Participants transition from DC to Glide control strategy and receive occupational therapy training

1 week

1 visit (in-person)

Treatment (B Phase)

Participants use the Glide prosthesis for treatment measurements and daily activities

10-14 weeks

Weekly data submission via web portal

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Glide Control Strategy

Trial Overview The study aims to determine if the Glide prosthesis offers better performance than the standard DC prosthesis. Subjects will first use the DC arm for up to 14 weeks followed by the Glide arm for the remaining time in a clinical setting and daily life.

How Is the Trial Designed?

Group I: Multiple Baseline Experimental Treatment 2 Interventions

Participants act as their own controls. Participants are fit with a prosthesis system, which includes IBT's Core2 controller, IBT Electrodes, FlexCell batteries, and prosthetic componentry chosen by the patient and their clinical team. The provided controller can operate in two modes of operation: (1) in Direct Control (or DC); and (2) using the Glide control strategy. Participants progress through an AB multiple baseline protocol, where they use the provided prosthesis system for four evaluation periods (totaling 24-weeks in duration). During the A-phase, participants use the system with DC and during the B-phase, participants use the system with the Glide control strategy. For both interventions, the required hardware is the same, while the control software will differ.

Glide Control Strategy is already approved in United States, European Union for the following indications:

Approved in United States as Glide Myoelectric Control Algorithm for:

• Upper limb amputation
• Partial hand limb loss

Approved in European Union as Glide Control Strategy for:

• Upper limb amputation
• Partial hand limb loss

Who Is Running the Clinical Trial?

Infinite Biomedical Technologies

Lead Sponsor

Trials

7

Recruited

160+

Advanced Arm Dynamics

Collaborator

Trials

1

Recruited

7+

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

Trials

2,103

Recruited

2,760,000+

Published Research Related to This Trial

Myoelectric control has been an effective method for controlling upper limb prostheses for over 30 years, demonstrating reliability and durability in various situations.

The future of prosthetic technology lies in integrating multiple control schemes and utilizing advancements like microprocessors to enhance functionality, aiming to better replicate the natural movement and appearance of the human arm.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Upper extremity myoelectric prosthetics. Uellendahl, JE.[2005]

The evaluation of the University of New Brunswick 3-state myoelectric control system involved 11 amputees and was conducted by a 14-person interdisciplinary team, ensuring a comprehensive assessment of the device's benefits.

This myoelectric control system allows for on/off control of a powered hand using a single muscle, making it suitable for patients with limited control sites, which could enhance functionality for below-elbow and forequarter amputees.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Clinical evaluation of UNB 3-state myoelectric control for arm prostheses. Paciga, JE., Gibson, DA., Gillespie, R., et al.[2007]

Recent advancements in prosthetic devices and neuroprosthetic control strategies have significantly improved the rehabilitation of amputees, allowing for more natural and intuitive use of prosthetic limbs.

Refined surgical techniques now enable precise recording and stimulation of nerve signals in residual limbs, enhancing the control of prosthetics and providing users with a more realistic experience.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Realizing Upper Extremity Bionic Limbs: Leveraging Neuroprosthetic Control Strategies. Ganesh Kumar, N., Chestek, CA., Cederna, PS., et al.[2023]

A study involving six transradial prosthesis users demonstrated that using a bespoke electrode housing unit significantly improved the functionality of myoelectric prostheses compared to conventional housings.

The research highlights that secure electrode contact and proper alignment with the residual limb are crucial for effective prosthesis use, suggesting that adjustable electrode housing can enhance performance, especially in challenging fitting situations.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

The use of an adjustable electrode housing unit to compare electrode alignment and contact variation with myoelectric prosthesis functionality: A pilot study. Head, JS., Howard, D., Hutchins, SW., et al.[2017]

A nine-year-old girl with a congenital above-elbow amputation successfully used a myoelectrically controlled prosthesis that allows her to control both the hand and elbow through muscle signals from her biceps and triceps.

Two control methods were tested: a three-level method and a contraction-rate detection method, with the latter proving to be more effective for the patient, leading to daily use and continuous improvement in her control abilities.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Myoelectric elbow and hand prosthesis controlled by signals from 2 muscles only, in a 9 year old girl. Philipson, L., Sörbye, R.[2017]

A novel method for controlling myoelectric upper limb prostheses involves transferring residual nerves to spare muscles, creating additional control signals that allow for more natural and simultaneous control of multiple prosthetic movements.

This technique has been successfully implemented in one shoulder disarticulation and one transhumeral amputee, resulting in a significant increase in functional range-of-motion and the ability to perform tasks like picking up objects, which were previously difficult.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Prosthetic command signals following targeted hyper-reinnervation nerve transfer surgery. Kuiken, T., Miller, L., Lipschutz, R., et al.[2022]

A new regression-based control method for myoelectric hand prostheses allows users to simultaneously and proportionally control two functions, improving usability compared to traditional methods that only allow one function at a time.

In tests involving daily life activities with five prosthetic users, this new approach demonstrated robust performance across different arm positions and days, outperforming existing clinical control techniques in most scenarios.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Simultaneous control of multiple functions of bionic hand prostheses: Performance and robustness in end users. Hahne, JM., Schweisfurth, MA., Koppe, M., et al.[2021]

A new evaluation tool was developed to objectively assess the performance of myoelectric control strategies for upper limb prostheses, showing that it effectively follows Fitts' law for both direct and pattern recognition control methods.

Pattern recognition control significantly outperformed direct control in terms of throughput, indicating it may provide better real-time control for users of myoelectric prostheses, while maintaining similar completion rates and path efficiencies.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Real-time comparison of conventional direct control and pattern recognition myoelectric control in a two-dimensional Fitts' law style test. Wurth, SM., Hargrove, LJ.[2020]

The new control scheme for myoelectric prostheses allows for a wider variety of grip types based on the user's muscle contractions, improving functionality for amputees.

This system utilizes adaptive control parameters tailored to the patient's anatomy, enhancing the responsiveness and usability of the FZK-prosthesis through real-time data processing by a microcontroller.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

[Expanding control possibilities of myoelectric hand prostheses]. Reischl, M., Mikut, R., Pylatiuk, C., et al.[2019]

The University of New Brunswick has been researching myoelectric controls for prosthetics since 1960, focusing on creating systems that cater to specific clinical needs, such as for amputees with limited muscle control.

Recent advancements in electromechanical systems suggest that more sophisticated multifunction prosthetic controls will soon be available for clinical use, enhancing functionality and appearance, especially for children and infants.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Myoelectric control systems research at the Bio-Engineering Institute, University of New Brunswick. Scott, RN.[2006]

Citations

1. withpower.com withpower.com/trial/phase-amputations-7-2024-812b4

Glide Control for Upper Extremity Amputation The Glide Control Strategy is unique because it uses a myoelectric control algorithm that allows for more natural and intuitive control of prosthetic limbs by ...

2. clinicaltrials.gov clinicaltrials.gov/study/NCT06539936?term=AREA%5BSponsorSearch%5D(COVERAGE%5BFullMatch%5DEXPANSION%5BNone%5D(%22Infinite%20Biomedical%20Technologies%22))&rank=1

Regulatory Clearance of the Glide Control Strategy for ... The investigators will test the following hypothesis: Use of Glide results in improved functional performance, satisfaction, and usage metrics as compared ...

3. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC7269158/

A Myoelectric Postural Control Algorithm for Persons With ... Here we studied the clinical readiness of the myoelectric postural control algorithm in a laboratory setting with two trans-radial amputees.

4. conferences.lib.unb.ca conferences.lib.unb.ca/mec/article/download/20/70

TAKE-HOME TRIAL OF THE GLIDE HAND AND WRIST ... Weir, “A Myoelectric Postural Control Algorithm for Persons with Transradial Amputation: A. Consideration of Clinical Readiness,” IEEE Robot. Autom. Mag., pp ...

5. mdpi.com mdpi.com/1424-8220/21/6/1953

Control Strategies and Performance Assessment of Upper ... In this section, for each study, we will analyze the most used strategies introduced to improve the prosthesis myoelectric control for TMR patients with PR ...

6. clinicaltrials.gov clinicaltrials.gov/study/NCT07222085

Long-Term Stability of the Glide Control Strategy This research is intended to test whether the prescription of the Glide prosthesis control system reduces the burden of use for both ...

7. conferences.lib.unb.ca conferences.lib.unb.ca/mec/en/article/download/2517/1843/3592

feasibility of the glide myoelectric control algorithm to While the number of individuals with partial hand limb loss is ten times greater than all other upper limb amputation categories combined, the state of ...

8. mdpi.com mdpi.com/2079-9292/8/11/1244

Myoelectric Control for Upper Limb Prostheses This work reviews the most recent literature in upper limb prosthetic control. It covers commonly used variants of possible biological inputs.